ArticleDigestive diseases and sciences2023

Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease Patients.

Gerum Gashaw Gebeyehu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.